Operating

Change in AP

Revolution Medicines, Inc. Change in AP decreased by 13.8% to $16.86M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 303.8%, from -$8.27M to $16.86M. This decline may warrant attention — for this metric, higher values are generally preferred.

Analysis

StatementCash Flow Statement
SectionOperating
CategoryLiquidity
SignalHigher is better
VolatilityModerate
First reportedQ1 2018
Last reportedQ1 2026May 6, 2026

How to read this metric

An increase is generally positive for cash flow, as it allows the company to retain cash longer, provided it does not damage supplier relationships.

Detailed definition

This measures the change in the amount the company owes to its suppliers and vendors for goods and services received. An...

Peer comparison

Standard metric; companies often aim to optimize payment terms to maximize cash availability.

Metric ID: change_in_accounts_payable

Historical Data

17 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q1 '25Q2 '25Q3 '25Q1 '26
Value$1.61M$189.00K$2.57M-$492.00K-$952.00K$10.24M-$1.05M$8.63M$580.00K$24.31M-$28.96M-$4.08M-$2.79M-$8.27M$8.76M$19.55M$16.86M
QoQ Change-88.2%>999%-119.1%-93.5%>999%-110.3%+922.3%-93.3%>999%-219.2%+85.9%+31.7%-196.6%+205.9%+123.1%-13.8%
YoY Change-159.2%>999%-113.4%>999%-94.3%<-999%-147.3%-580.7%+71.4%+314.7%+801.0%+303.8%
Range-$28.96M$24.31M
CAGR+79.9%
Avg YoY Growth+338.5%
Median YoY Growth-11.4%

Frequently Asked Questions

What is Revolution Medicines, Inc.'s change in ap?
Revolution Medicines, Inc. (RVMD) reported change in ap of $16.86M in Q1 2026.
How has Revolution Medicines, Inc.'s change in ap changed year-over-year?
Revolution Medicines, Inc.'s change in ap increased by 303.8% year-over-year, from -$8.27M to $16.86M.
What does change in ap mean?
The change in money the company owes to its suppliers.